Menu
Find Research . . . .
Outputs
New search
Researchers
Research units
Sign in
Back
Journal article
Open access
In Vitro Validation of miRNA-Mediated Gene Expression Linked to Drug Metabolism
Botros B Shenoda
,
Sujay Ramanathan
and
Seena K Ajit
Show details for 3 authors
Current protocols in pharmacology, v 79(1), pp 9.26.1-9.26.15
20 Dec 2017
DOI:
https://doi.org/10.1002/cpph.30
PMCID: PMC6512327
PMID: 29261225
Share
Export
Files and links (1)
Abstract
Metrics
Details
Files and links (1)
url
https://europepmc.org/articles/pmc6512327
View
Accepted (AM)
Open Access (License Unspecified)
, Open
Abstract
Gene Expression Regulation
Glucuronosyltransferase - genetics
Glucuronosyltransferase - metabolism
HEK293 Cells
Hep G2 Cells
Humans
MicroRNAs - genetics
MicroRNAs - metabolism
Pharmaceutical Preparations - metabolism
RNA, Messenger - genetics
Pharmacogenomic approaches used to investigate how genes affect drug responses are critical for designing personalized therapies aimed at maximizing efficacy and minimizing adverse effects. Drug efficacy is often dependent on the sequence and expression levels of drug target genes or those involved in the metabolism and transport of the therapeutic agent. Expression of these genes, in turn, is negatively regulated by small noncoding miRNAs. The levels of miRNAs in bodily fluids have been studied extensively as potential diagnostic and prognostic biomarkers. Studies have shown that miRNAs regulate multiple genes and sequence homology is used to predict which genes are subject to regulation by a particular miRNA. Once a gene is identified as a potential target for an miRNA of interest, experiments are undertaken to confirm that the miRNA interacts with the target gene and can alter its level of expression and/or its activity. For example, the differential expression of miRNAs in whole blood obtained from good and poor responders to ketamine has been reported both prior to, and following treatment for complex regional pain syndrome. In this case, hsa-miR-548d-5p was significantly lower in poor responders relative to good responders. This miRNA was predicted to target UDP-glucuronyl transferase 1A1 (UGT1A1), a key drug metabolizing enzyme. Described in this unit are protocols used to confirm miR-548d-5p-mediated UGT1A1 regulation. The approaches described can be employed broadly for the validation of miRNA-mediated negative regulation of any gene. Determining miRNA-mediated regulation of enzymes and transporters affecting drug metabolism is a critical step in designing personalized therapy and for understanding the mechanisms responsible for variations in the responses to therapeutic agents. © 2017 by John Wiley & Sons, Inc.
Expand abstract
Metrics
8
Record Views
5
citations in Scopus
See more details
Posted by
1
X users
11
readers on Mendeley
Details
Title
In Vitro Validation of miRNA-Mediated Gene Expression Linked to Drug Metabolism
Creators
Botros B Shenoda - Drexel University
Sujay Ramanathan - Drexel University
Seena K Ajit - Drexel University
Publication Details
Current protocols in pharmacology, v 79(1), pp 9.26.1-9.26.15
Publisher
Wiley
Grant note
R21 NS082991 / NINDS NIH HHS R01 NS102836 / NINDS NIH HHS
Resource Type
Journal article
Language
English
Academic Unit
Pharmacology and Physiology
Scopus ID
2-s2.0-85042673876
Other Identifier
991019173798804721
Show the rest
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services
Visit the Office of Research & Innovation website
Browse and search our researcher profiles
For display interface
https://europepmc.org/articles/pmc6512327